SYF
69
4
BK
72
4
UHS
64
4
EXC
69
-3
AIV
43
2
TROW
40
8
FITB
62
3
JPM
67
5
STT
64
7
LRCX
50
2
LOW
39
2
PNR
51
4
WM
74
3
IVZ
43
4
URBN
56
5
AVB
50
3
NDAQ
64
4
APH
70
6
LEG
31
2
NOC
43
-2
SYF
69
4
BK
72
4
UHS
64
4
EXC
69
-3
AIV
43
2
TROW
40
8
FITB
62
3
JPM
67
5
STT
64
7
LRCX
50
2
LOW
39
2
PNR
51
4
WM
74
3
IVZ
43
4
URBN
56
5
AVB
50
3
NDAQ
64
4
APH
70
6
LEG
31
2
NOC
43
-2
Financhill
Back

Greenpro Capital Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
37

GRNQ
Greenpro Capital

Last Price:
$0.93
Seasonality Move:
11.9%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$73.63
Seasonality Move:
14.66%
Sell
37
Greenpro Capital (GRNQ) is a Sell

Is Greenpro Capital a Buy, Sell or Hold?

  • The current Greenpro Capital [GRNQ] share price is $0.93. The Score for GRNQ is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • GRNQ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GRNQ Stock Price Chart

What is Greenpro Capital's stock price today?

  • The Greenpro Capital share price today is $0.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRNQ is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $76.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

GRNQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 45.44 Sell
Chaikin Money Flow: -2033 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.91 - 1.01) Sell
Bollinger Bands (100): (0.89 - 1.15) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.07 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: 1304026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.54 - 110.54) Sell
Bollinger Bands (100): (102.23 - 127.85) Sell

GRNQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.91 Buy
20-day SMA: 0.94 Sell
50-day SMA: 1.02 Sell
200-day SMA: 1 Sell
8-day EMA: 0.92 Buy
20-day EMA: 0.94 Sell
50-day EMA: 0.99 Sell
200-day EMA: 1.05 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.29 Sell
20-day SMA: 96.26 Sell
50-day SMA: 107.61 Sell
200-day SMA: 124.92 Sell
8-day EMA: 82.75 Sell
20-day EMA: 92.99 Sell
50-day EMA: 104.03 Sell
200-day EMA: 117.97 Sell

Greenpro Capital Earnings Growth & GRNQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Greenpro Capital Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):